# Globus Medical to buy NuVasive in $3 billion all-stock deal

Medical device maker Globus Medical agreed to acquire smaller competitor NuVasive in an all-stock transaction valued at over $3 billion.

- Type: Acquisition
- Announced: 2023-02-09
- Where: United States
- Value: $3.00B
- Status: announced
- Products: musculoskeletal technology products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [NuVasive Inc.](https://endata.com/companies/21854.md) (target)
- [Globus Medical](https://endata.com/companies/26057.md) (acquirer)

## Sources

- [news.bloomberglaw.com](https://news.bloomberglaw.com/mergers-and-acquisitions/globus-medical-to-buy-nuvasive-in-3-billion-all-stock-deal), 2023-02-09: "This transaction reflects our mission to become the leading musculoskeletal technology company in the world by developing products that promote healing in ..."
- [nuvasive.com](https://www.nuvasive.com/news/globus-medical-and-nuvasive-to-combine-in-all-stock-transaction-to-create-innovative-global-musculoskeletal-company-focused-on-patient-care/), 2023-02-09: "This transaction reflects our mission to become the leading musculoskeletal technology company in the world by developing products that promote healing in patients with musculoskeletal disorders."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.